Background illustration for clinical trials search

Paid Clinical Trials Kent

Discover 1,441 paid clinical trials in Kent, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Digital Intervention (ACT on Vaping App) for Vaping Cessation in Young Adult E-Cigarette Users

for
Nicotine Dependence, Tobacco-Related Carcinoma
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 18 - 30

Code: NCT06909500

Recruiting

A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion

for
Metastatic Non-small Cell Lung Cancer With MTAP Deletion
Location: Seattle WA, Portland OR, Boise ID, Salt Lake City UT,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07063745

Phase2, Phase3, Recruiting

Nemtabrutinib and Lisocabtagene Maraleucel for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

for
Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 18+

Code: NCT07194980

Phase2, Recruiting

A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases

for
Chronic Inflammatory Demyelinating Polyneuropathy,
Location: Seattle WA, Salt Lake City UT, Palo Alto CA,
Sponsor: Kite, A Gilead Company

Sex: All

Age: 18 - 70+

Code: NCT07304154

Phase1, Recruiting

Inobrodib, Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma Refractory, Multiple Myeloma in Relapse
Location: Seattle WA, San Francisco CA, Phoenix AZ, Omaha NE,
Sponsor: CellCentric Ltd.

Sex: All

Age: 18+

Code: NCT07096778

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)

for
Breast Cancer
Location: Seattle WA, Billings MT, Los Angeles CA, Fullerton CA,
Sponsor: Celcuity Inc

Sex: All

Age: 18+

Code: NCT06757634

Phase3, Recruiting

Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

for
Prostate Cancer
Location: Seattle WA, Springfield OR, Palo Alto CA, Murray UT,
Sponsor: Novartis Pharmaceuticals

Sex: Male

Age: 18 - 70+

Code: NCT06780670

Phase2, Phase3, Recruiting

Exercise Training for the Improvement of Immune Activity and Treatment Outcomes During Immunotherapy for Non-small Cell Lung Cancer, BOOST Trial

for
Lung Non-Small Cell Carcinoma
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 18+

Code: NCT06983899

Recruiting

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors, Advanced Breast Cancer
Location: Seattle WA, San Francisco CA, Newport Beach CA,
Sponsor: Ensem Therapeutics

Sex: All

Age: 18+

Code: NCT06993844

Phase1, Phase2, Recruiting

Evaluating the Effects of Hemoglobin Threshold-specific Packed Red Blood Cell Transfusions on Quality of Life and Functional Outcomes in Patients With High-grade Myeloid Neoplasms, Acute Myeloid Leukemia, or B Acute Lymphoblastic Lymphoma/Leukemia

for
Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia,
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18+

Code: NCT06710418

Recruiting

HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

for
Juvenile Myelomonocytic Leukemia,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 0 - 70+

Code: NCT03326921

Phase1, Recruiting

A Digital Smoking Cessation Intervention for Helping American Indians and Alaska Natives Quit Smoking, IndigeQuit Trial

for
Cigarette Smoking-Related Carcinoma
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 18+

Code: NCT06145763

Recruiting

A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer

for
Prostatic Neoplasms
Location: Seattle WA, Cleveland OH, New York NY, Sarasota FL
Sponsor: Janssen Research & Development, LLC

Sex: Male

Age: 18+

Code: NCT07082920

Phase1, Recruiting

Axatilimab for Sclerotic Chronic Graft-versus-Host Disease

for
Chronic Graft Versus Host Disease
Location: Seattle WA, Boston MA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 18+

Code: NCT07011810

Phase2, Recruiting

Odronextamab for Relapsed and Refractory Large B-cell Lymphomas Before CAR-T

for
Recurrent Diffuse Large B-Cell Lymphoma,
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18+

Code: NCT06784726

Phase2, Recruiting

This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma

for
Non-Hodgkin Lymphoma Refractory/ Relapsed,
Location: Seattle WA, Duarte CA, St Louis MO, Nashville TN,
Sponsor: LTZ Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07121946

Phase1, Recruiting

A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)

for
Malignant Melanoma
Location: Seattle WA, San Francisco CA, Springdale AR, Brampton,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06961006

Phase2, Recruiting

Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors

for
Melanoma, Medullary Thyroid Cancer,
Location: Seattle WA, Tucson AZ
Sponsor: University of Arizona

Sex: All

Age: 18 - 70+

Code: NCT06814496

Phase1, Phase2, Recruiting

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

for
Pancreatic Neuroendocrine Tumor (pNET),
Location: Seattle WA, Portland OR, Vallejo CA, Palo Alto CA,
Sponsor: Exelixis

Sex: All

Age: 18+

Code: NCT06943755

Phase2, Phase3, Recruiting

Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hematopoietic Cell Transplant for the Treatment of Adults Age 60 and Older With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia or Other High-Grade Myeloid Cancer

for
Acute Leukemia of Ambiguous Lineage, Acute Myeloid Leukemia,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 18+

Code: NCT07046078

Phase2, Recruiting